RATIONAL DESIGN OF THROMBOXANE A2 ANTAGONISTS

被引：0
|
作者：
HAMANAKA, N
SEKO, T
MIYAZAKI, T
KAWASAKI, A
机构：
来源：
ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 1991年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：359 / 362
页数：4
相关论文
共 50 条
  • [31] A Novel Antagonist for the Thromboxane A2 Receptor
    Khasawneh, Fadi T.
    Ting, Harold J.
    FASEB JOURNAL, 2010, 24
  • [32] THROMBOXANE-A2 SYNTHETASE INHIBITORS AND THROMBOXANE-A2 RECEPTOR ANTAGONISTS
    TERAO, S
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1987, 45 (01) : 2 - 13
  • [33] The β1-Subunit of the MaxiK Channel Associates with the Thromboxane A2 Receptor and Reduces Thromboxane A2 Functional Effects
    Li, Min
    Zhang, Zhu
    Koh, Huilin
    Lu, Rong
    Jiang, Zhaorong
    Alioua, Abderrahmane
    Garcia-Valdes, Jesus
    Stefani, Enrico
    Toro, Ligia
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (05) : 3668 - 3677
  • [34] Synthesis and pharmacological evaluation of 2-aryloxy/arylamino-5-cyanobenzenesulfonylureas as novel thromboxane A2 receptor antagonists
    Bambi-Nyanguile, Sylvie-Mireille
    Hanson, Julien
    Ooms, Annie
    Alpan, Lutfiye
    Kolh, Philippe
    Dogne, Jean-Michel
    Pirotte, Bernard
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 65 : 32 - 40
  • [35] Rational design of CCR2 antagonists: a survey of computational studies
    Sobhia, Masilamani Elizabeth
    Singh, Rajesh
    Kare, Pavan
    Chavan, Swapnil
    EXPERT OPINION ON DRUG DISCOVERY, 2010, 5 (06) : 543 - 557
  • [36] Synthesis and biological activity of 4-methyl-3,5-dioxane derivatives as thromboxane A2 receptor antagonists
    Marusawa, H
    Setoi, H
    Kuroda, A
    Sawada, A
    Seki, J
    Motoyama, Y
    Tanaka, H
    BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (11) : 2635 - 2645
  • [37] PHARMACOLOGY OF THROMBOXANE-A2 RECEPTOR ANTAGONISTS
    HALUSHKA, PV
    ZEITSCHRIFT FUR KARDIOLOGIE, 1989, 78 : 42 - 47
  • [38] BM-613, a new thromboxane A2 antagonist, is characterized by a preferential activity on platelet thromboxane A2 receptors.
    Hanson, J
    Rolin, S
    de Leval, X
    Neven, P
    de Leval, L
    Masereel, B
    Pirotte, B
    Dogné, JM
    BLOOD, 2003, 102 (11) : 813A - 814A
  • [39] POTENTIAL OF COMBINED THROMBOXANE A2 AND SEROTONIN ANTAGONISTS - TO PREVENT THE DEVELOPMENT OF UNSTABLE ANGINA AND ACUTE MYOCARDIAL-INFARCTION
    WILLERSON, JT
    BUJA, LM
    TEXAS HEART INSTITUTE JOURNAL, 1990, 17 (03) : 157 - 164
  • [40] Development of dual-acting benzofurans and benzomorpholines as dual thromboxane A2 receptor antagonists and prostacyclin receptor agonists
    Ohno, Michihiro
    Takeda, Takahiro
    Tanaka, Yoichiro
    Makita, Kei
    Miyamoto, Mitsuko
    Yamada, Naohiro
    Ohtake, Atsushi
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2560 - U2560
12345